个性化医疗
药效学
医学
药代动力学
精密医学
药理学
计算生物学
计算机科学
生物信息学
生物
病理
作者
Jian Yang,Xia Gong,Ying Zheng,Hong Duan,Shuijin Chen,Tong Wu,Changqing Yi,Lelun Jiang,Hossam Haick
标识
DOI:10.1038/s41467-025-61549-9
摘要
Precision and personalized medicine for disease management necessitates real-time, continuous monitoring of biomarkers and therapeutic drugs to adjust treatment regimens based on individual patient responses. This study introduces a wearable Microneedle-based Continuous Biomarker/Drug Monitoring (MCBM) system, designed for the simultaneous, in vivo pharmacokinetic and pharmacodynamic evaluation for diabetes. Utilizing a dual-sensor microneedle and a layer-by-layer nanoenzyme immobilization strategy, the MCBM system achieves high sensitivity and specificity in measuring glucose and metformin concentrations in skin interstitial fluid (ISF). Seamless integration with a smartphone application enables real-time data analysis and feedback, fostering a pharmacologically informed approach to diabetes management. The MCBM system's validation and in vivo trials demonstrate its precise monitoring of glucose and metformin, offering a tool for personalized treatment adjustments. Its proven biocompatibility and safety suit long-term usage. This system advances personalized diabetes care, highlighting the move towards wearables that adjust drug dosages in real-time, enhancing precision and personalized medicine.
科研通智能强力驱动
Strongly Powered by AbleSci AI